ProBioGen AG | ProBioGen

Germany-based expert in the development and manufacturing of biopharmaceuticals, viral vectors, and vaccines, powered by proprietary technologies that enhance product quality and features. We combine integrated services with our proprietary platforms and technologies, to enable fast, integrated cell line and process development, comprehensive analytics, and reliable GMP-compliant manufacturing, all supported by a highly experienced team.

Operating for over 30 years, the CDMO company runs three manufacturing lines, where 300 employees contribute to advancing next-generation therapies and global biotech innovation. The company’s growth strategy focuses on expanding its service value chain through organic growth and strategic opportunities, with a clear mission to enable tomorrow’s biopharmaceuticals.